Citations

Citations to this article as recorded by  

• Factors Associated With Decision to Treat or Not to Treat Helicobacter pylori Infection in Children: Data From the EuroPedHp Registry
  Thu Giang Le Thi, Katharina Werkstetter, Kallirroi Kotilea, Patrick Bontems, José Cabral, Maria Luz Cilleruelo, Michal Kori, Josefa Barrio, Matjaž Homan, Nicolas Kalach, Rosa Lima, Marta Tavares, Pedro Urruzuno, Zrinjka Misak, Vaidotas Urbonas, Sibylle Ko
  Helicobacter.2024;[Epub]     CrossRef
• Impact of Helicobacter pylori Eradication on Inflammatory Bowel Disease Onset and Disease Activity: To Eradicate or Not to Eradicate?
  Antonietta Gerarda Gravina, Raffaele Pellegrino, Veronica Iascone, Giovanna Palladino, Alessandro Federico, Rocco Maurizio Zagari
  Diseases.2024; 12(8): 179.     CrossRef
• Bibliometric analysis of the correlation between H. pylori and inflammatory bowel disease
  Yantong Li, Limin Li, Wenmeng Yin, Juyi Wan, Xiaolin Zhong
  JGH Open.2024;[Epub]     CrossRef
• Discussion on the common controversies of Helicobacter pylori infection
  Hang Yang, Yi Mou, Bing Hu
  Helicobacter.2023;[Epub]     CrossRef
• Helicobacter pylori and Inflammatory Bowel Disease: An Unresolved Enigma
  Juris Pokrotnieks, Stanislav Sitkin
  Inflammatory Bowel Diseases.2023; 29(3): e5.     CrossRef
• Helicobacter Pylori and Autoimmune Diseases: Involving Multiple Systems
  Li Wang, Zheng-Min Cao, Li-Li Zhang, Xin-can Dai, Zhen-ju Liu, Yi-xian Zeng, Xin-Ye Li, Qing-Juan Wu, Wen-liang Lv
  Frontiers in Immunology.2022;[Epub]     CrossRef
• Helicobacter pylori infection in patients with inflammatory bowel diseases: a single-centre, prospective, observational study in Egypt
  Ekram W. Abd El-Wahab, Ebtessam I. Youssef, Ehab Hassouna
  BMJ Open.2022; 12(5): e057214.     CrossRef
• Is the Presence of Helicobacter Pylori in the Colonic Mucosa, Provocative of Activity in Ulcerative Colitis?
  Javad Ranjbar, Bita Geramizadeh, Kamran Bagheri Lankarani, Zahra Jowkar, Mitra Mirzai, Elham Moazamian
  Clinical Pathology.2022;[Epub]     CrossRef
• Helicobacter pylori infection and inflammatory bowel diseases
  Yu. P. Uspenskiy, N. V. Baryshnikova, A. N. Suvorov, A. V. Svarval
  Russian Journal of Infection and Immunity.2021; 11(1): 68.     CrossRef
• Ulcerative colitis relapse after Helicobacter pylori eradication in a 12-year-old boy with duodenal ulcer
  Yuji Fujita, Keiichi Tominaga, Takanao Tanaka, Takeshi Sugaya, Shigemi Yoshihara
  BMC Gastroenterology.2021;[Epub]     CrossRef
• Effect of sequential eradication therapy on serum osteoprotegerin levels in patients with Helicobacter pylori infection and co-existing inflammatory bowel disease
  Hussam Murad, Misbahuddin Rafeeq, Mahmoud Mosli, Mamdouh Gari, Mohammed Basheikh
  Journal of International Medical Research.2021;[Epub]     CrossRef
• Extra-Gastric Manifestations of Helicobacter pylori Infection
  Antonietta G. Gravina, Kateryna Priadko, Paola Ciamarra, Lucia Granata, Angela Facchiano, Agnese Miranda, Marcello Dallio, Alessandro Federico, Marco Romano
  Journal of Clinical Medicine.2020; 9(12): 3887.     CrossRef
• Comparison of new and classical point mutations associated with clarithromycin resistance in Helicobacter pylori strains isolated from dyspeptic patients and their effects on phenotypic clarithromycin resistance
  Bekir Kocazeybek, Merve Kutlu Sakli, Pelin Yuksel, Mehmet Demirci, Reyhan Caliskan, Tevhide Ziver Sarp, Suat Saribas, Suleyman Demiryas, Fatma Kalayci, Huseyin Cakan, Hayriye Kirkoyun Uysal, Nesrin Gareayaghi, Sevgi Ergin, Yusuf Ziya Erzin, Kadir Bal, İhs
  Journal of Medical Microbiology .2019; 68(4): 566.     CrossRef
• Review:Helicobacter pyloriand extragastric diseases
  Francesco Franceschi, Marcello Covino, Claire Roubaud Baudron
  Helicobacter.2019;[Epub]     CrossRef

A 75-year-old man was admitted to our hospital with sudden onset of vomiting and abdominal distension. The patient was taking medication for arrhythmia. Computed tomography showed stenosis of the ileum and a small bowel dilatation on the oral side from the region of stenosis. A transnasal ileus tube was placed. Enteroclysis using contrast medium revealed an approximately 6-cm afferent tubular stenosis 10 cm from the terminal ileum and thumbprinting in the proximal bowel. Transanal double-balloon enteroscopy showed a circumferential shallow ulcer with a smooth margin and edema of the surrounding mucosa. The stenosis was so extensive that we could not perform endoscopic balloon dilation therapy. During hospitalization, the patient's nutritional status deteriorated. In response, we surgically resected the region of stenosis. Histologic examination revealed disappearance of the mucosal layer and transmural ulceration with marked fibrosis, especially in the submucosal layer. Hemosiderin staining revealed sideroferous cells in the submucosal layers. Based on the pathologic findings, the patient was diagnosed with ischemic enteritis. The patient's postoperative course was uneventful.

Citations

Citations to this article as recorded by  

• Myeloid Sarcoma in the Small Intestine
  Masaya Iwamuro, Tomohiro Kamio, Shoichiro Hirata, Katsunori Matsueda, Daisuke Kametaka, Takehiro Tanaka, Seiji Kawano, Motoyuki Otsuka
  Internal Medicine.2025;[Epub]     CrossRef
• Spontaneous multiple small bowel perforations due to ischemic enteritis: a case report
  Cheru Lilay Gebrehiwet, Aklilu Yiheyis Abereha, Dawit Aysheshim Mulualem, Misgana Lemma Gurmu, Samuel Addisu Abera, Amanuel Kassa Tadesse, Girma Damtew Adisu, Ermias Teklehaimanot Yefter, Melaku Tessema kassie
  BMC Geriatrics.2025;[Epub]     CrossRef
• Late Graft Failure Due to Arterio-Venous Fistula in the Free Jejunal Graft Mesentery Following Total Pharyngo-Laryngo-Esophagectomy for Cervical Esophageal Cancer: A Case Report
  Koutarou Yamamoto, Tomoyuki Okumura, Takeshi Miwa, Yoshihisa Numata, Tatsuhiro Araki, Ayaka Itoh, Mina Fukasawa, Nana Kimura, Masakazu Nagamori, Kosuke Mori, Naoya Takeda, Tomohiro Minagawa, Kenta Sukegawa, Toru Watanabe, Katsuhisa Hirano, Isaya Hashimoto
  Surgical Case Reports.2025; 11(1): n/a.     CrossRef
• Clinical characteristics and surgical management of ileal strictures caused by ischemic enteritis: a report of three cases
  Yuya Kondo, Shingo Tsujinaka, Tomoya Miura, Yoh Kitamura, Yoshihiro Sato, Kentaro Sawada, Atsushi Mitamura, Toru Nakano, Yu Katayose, Chikashi Shibata
  Journal of Surgical Case Reports.2025;[Epub]     CrossRef
• Smooth muscle degeneration of the mesenteric and branching veins causing ischemic enteritis: a case report
  Taiki Sunakawa, Nobuo Ito, Ryo Moriyasu, Nobuya Seki, Daisuke Takeuchi, Kotaro Sasahara
  Surgical Case Reports.2022;[Epub]     CrossRef
• Ischemic enteritis resulting from polycythemia vera
  Soichi Yagi, Kiyohide Kioka, Yurina Koizumi, Takashi Nakai, Yasuko Kawasaki, Minako Tsutsumi, Naomi Ishii, Tomoaki Yamasaki, Hiroko Nebiki, Kiyoshi Maeda
  Clinical Journal of Gastroenterology.2022; 15(5): 907.     CrossRef
• Association of decreased variation of coefficient R–R interval with ischemic colitis and small bowel obstruction
  Toshio Arai, Hiroki Yamada, Takeya Edagawa, Satoshi Yoshida, Shigetoshi Hikimoto, Hiromichi Sougawa, Kenichiro Nakachi, Raffaele Serra
  PLOS ONE.2020; 15(2): e0228117.     CrossRef
• Ileítis isquémica idiopática, con sangrado digestivo oscuro manifiesto
  Gabriel Mosquera-Klinger, Reinaldo Andrés Rincón
  Gastroenterología y Hepatología.2019; 42(7): 439.     CrossRef
• Small bowel strictures
  Deniz Durmush, Arthur J. Kaffes
  Current Opinion in Gastroenterology.2019; 35(3): 235.     CrossRef
• Ultrasonographic and histopathological features in 8 cats with fibrotic small intestinal stricture
  Andrew Holloway, Mauro Pivetta, Roberta Rasotto
  Veterinary Radiology & Ultrasound.2019; 60(4): 423.     CrossRef
• Experience with Balloon Dilatation in Crohn’s and Non-Crohn’s Benign Small-Bowel Strictures: Is There a Difference?
  Akiyoshi Tsuboi, Shiro Oka, Shinji Tanaka, Sumio Iio, Ichiro Otani, Sayoko Kunihara, Ryohei Hayashi, Kazuaki Chayama
  Gastroenterology Research and Practice.2019; 2019: 1.     CrossRef
• Idiopathic ischaemic ileitis, with overt obscure digestive bleeding
  Gabriel Mosquera-Klinger, Reinaldo Andrés Rincón
  Gastroenterología y Hepatología (English Edition).2019; 42(7): 439.     CrossRef
• Stenotic Ischemic Enteritis with Concomitant Hepatic Portal Venous Gas and Pneumatosis Cystoides Intestinalis
  Naoto Iwai, Osamu Handa, Yuji Naito, Osamu Dohi, Tetsuya Okayama, Naohisa Yoshida, Kazuhiro Kamada, Kazuhiko Uchiyama, Takeshi Ishikawa, Tomohisa Takagi, Hideyuki Konishi, Yoshito Itoh
  Internal Medicine.2018; 57(14): 1995.     CrossRef
• Etiology and long‐term rebleeding of endoscopic ulcerative lesions in the small bowel in patients with obscure gastrointestinal bleeding: A multicenter cohort study
  Tomonori Aoki, Atsuo Yamada, Yoshihiro Hirata, Hirobumi Suzuki, Ayako Nakada, Ryota Niikura, Motoko Seto, Makoto Okamoto, Kazuhiko Koike
  Journal of Gastroenterology and Hepatology.2018; 33(7): 1327.     CrossRef

Citations

Citations to this article as recorded by  

• Deep mucosal healing in ulcerative colitis: how deep is better?
  Xin Jin, Yan You, Gechong Ruan, Weixun Zhou, Ji Li, Jingnan Li
  Frontiers in Medicine.2024;[Epub]     CrossRef
• Systematic review and meta-analysis: the advantage of endoscopic Mayo score 0 over 1 in patients with ulcerative colitis
  Angelo Viscido, Marco Valvano, Gianpiero Stefanelli, Annalisa Capannolo, Chiara Castellini, Eugenia Onori, Antonio Ciccone, Filippo Vernia, Giovanni Latella
  BMC Gastroenterology.2022;[Epub]     CrossRef
• Predicting Ulcerative Colitis Relapse in Clinical Remission With Fecal Immunochemical Occult Blood Test or Prostaglandin E-Major Urinary Metabolite
  Natsuki Ishida, Tomoharu Matsuura, Yusuke Asai, Takahiro Miyazu, Satoshi Tamura, Shinya Tani, Mihoko Yamade, Moriya Iwaizumi, Yasushi Hamaya, Satoshi Osawa, Takahisa Furuta, Ken Sugimoto
  Clinical and Translational Gastroenterology.2022; 13(7): e00501.     CrossRef
• Further research on the clinical relevance of the ulcerative colitis colonoscopic index of severity for predicting 5-year relapse
  Natsuki Ishida, Shunya Onoue, Takahiro Miyazu, Satoshi Tamura, Shinya Tani, Mihoko Yamade, Moriya Iwaizumi, Yasushi Hamaya, Satoshi Osawa, Takahisa Furuta, Ken Sugimoto
  International Journal of Colorectal Disease.2021; 36(12): 2661.     CrossRef
• Predictive factors for achievement of mucosal healing by budesonide 2-mg foam in ulcerative colitis: a pooled analysis of data from two clinical trials
  Toshifumi Hibi, Makoto Naganuma, Eisei Oda, Yoji Yamada, Yoshitomo Chujoh, Ryoichi Yoshihara, Mamoru Watanabe
  Intestinal Research.2020; 18(1): 56.     CrossRef
• Incremental Benefit of Achieving Endoscopic and Histologic Remission in Patients With Ulcerative Colitis: A Systematic Review and Meta-Analysis
  Hyuk Yoon, Sushrut Jangi, Parambir S. Dulai, Brigid S. Boland, Larry J. Prokop, Vipul Jairath, Brian G. Feagan, William J. Sandborn, Siddharth Singh
  Gastroenterology.2020; 159(4): 1262.     CrossRef
• Middle-term prognosis in patients with ulcerative colitis who achieved clinical and endoscopic remission by budesonide rectal foam
  Makoto Naganuma, Fumihito Hirai, Kiyonori Kobayashi, Kenji Watanabe, Ken Takeuchi, Nobuo Aoyama, Hiroshi Nozawa, Satoshi Motoya, Toshihide Ohmori, Akio Harada, Yushi Nagai, Takayuki Abe, Yoji Yamada, Katsutoshi Inagaki, Naoki Shimizu, Takanori Kanai, Mamo
  PLOS ONE.2019; 14(8): e0220413.     CrossRef
• Endoscopic score vs. fecal biomarkers for predicting relapse in patients with ulcerative colitis after clinical remission and mucosal healing
  Takayuki Yamamoto, Takahiro Shimoyama, Satoru Umegae, Koichi Matsumoto
  Clinical and Translational Gastroenterology.2018; 9(3): e136.     CrossRef
• European Crohn’s and Colitis Organisation Topical Review on Treatment Withdrawal [‘Exit Strategies’] in Inflammatory Bowel Disease
  Glen Doherty, Konstantinos H Katsanos, Johan Burisch, Matthieu Allez, Konstantinos Papamichael, Andreas Stallmach, Ren Mao, Ingrid Prytz Berset, Javier P Gisbert, Shaji Sebastian, Jarosław Kierkuś, Loris Lopetuso, Edyta Szymanska, Edouard Louis
  Journal of Crohn's and Colitis.2018; 12(1): 17.     CrossRef
• Evaluation of the Potential Antioxidant Role of High-Density Lipoprotein-Cholesterol (HDL-C) in Patients with Ulcerative Colitis
  Mostafa Vaghari Tabari, Soheila Moein, Durdi Qujeq, Mehrdad Kashifard, Javaad Shokri Shirvani, Karimollah Hajian Tilaki, Gholamreza Farshidfar
  Annals of Colorectal Research.2017;[Epub]     CrossRef

Citations

Citations to this article as recorded by  

• Thiopurines Have Sustained Long-term Effectiveness in Patients with Inflammatory Bowel Disease, Which is Independent of Disease Duration at Initiation: A Propensity Score Matched Analysis
  Mukesh Kumar Ranjan, Peeyush Kumar, Sudheer Kumar Vuyyuru, Bhaskar Kante, Sandeep K Mundhra, Rithvik Golla, Shubi Virmani, Raju Sharma, Peush Sahni, Prasenjit Das, Mani Kalaivani, Ashish Datt Upadhyay, Govind Makharia, Saurabh Kedia, Vineet Ahuja
  Journal of Crohn's and Colitis.2024; 18(2): 192.     CrossRef
• Efficacy of drug and endoscopic treatment of Crohn's disease strictures: A systematic review
  Julien D Schulberg, Emily K Wright, Bronte A Holt, Helen E Wilding, Amy L Hamilton, Alyson L Ross, Michael A Kamm
  Journal of Gastroenterology and Hepatology.2021; 36(2): 344.     CrossRef
• Short-term tolerability and effectiveness of methotrexate monotherapy in adult patients with Crohn’s disease: a retrospective study
  Hee Seung Hong, Kyuwon Kim, Kyunghwan Oh, Jae Yong Lee, Seung Wook Hong, Jin Hwa Park, Sung Wook Hwang, Dong-Hoon Yang, Byong Duk Ye, Jeong-Sik Byeon, Seung-Jae Myung, Suk-Kyun Yang, Sang Hyoung Park
  Therapeutic Advances in Gastroenterology.2021;[Epub]     CrossRef
• NUDT15,FTO, andRUNX1genetic variants and thiopurine intolerance among Japanese patients with inflammatory bowel diseases
  Toshiyuki Sato, Tetsuya Takagawa, Yoichi Kakuta, Akihiro Nishio, Mikio Kawai, Koji Kamikozuru, Yoko Yokoyama, Yuko Kita, Takako Miyazaki, Masaki Iimuro, Nobuyuki Hida, Kazutoshi Hori, Hiroki Ikeuchi, Shiro Nakamura
  Intestinal Research.2017; 15(3): 328.     CrossRef
• Importance of Patients’ Knowledge of Their Prescribed Medication in Improving Treatment Adherence in Inflammatory Bowel Disease
  Chung Hyun Tae, Sung-Ae Jung, Hye Sung Moon, Jung-A Seo, Hye Kyung Song, Chang Mo Moon, Seong-Eun Kim, Ki-Nam Shim, Hye-Kyung Jung
  Journal of Clinical Gastroenterology.2016; 50(2): 157.     CrossRef

Citations

Citations to this article as recorded by  

• Thiopurines Have Sustained Long-term Effectiveness in Patients with Inflammatory Bowel Disease, Which is Independent of Disease Duration at Initiation: A Propensity Score Matched Analysis
  Mukesh Kumar Ranjan, Peeyush Kumar, Sudheer Kumar Vuyyuru, Bhaskar Kante, Sandeep K Mundhra, Rithvik Golla, Shubi Virmani, Raju Sharma, Peush Sahni, Prasenjit Das, Mani Kalaivani, Ashish Datt Upadhyay, Govind Makharia, Saurabh Kedia, Vineet Ahuja
  Journal of Crohn's and Colitis.2024; 18(2): 192.     CrossRef
• Potential benefits of immunomodulator use with vedolizumab for maintenance of remission in ulcerative colitis
  Makoto Naganuma, Kenji Watanabe, Satoshi Motoya, Haruhiko Ogata, Toshiyuki Matsui, Yasuo Suzuki, Lyann Ursos, Shigeru Sakamoto, Mitsuhiro Shikamura, Tetsuharu Hori, Jovelle Fernandez, Mamoru Watanabe, Toshifumi Hibi, Takanori Kanai
  Journal of Gastroenterology and Hepatology.2022; 37(1): 81.     CrossRef
• Real-World Long-Term Remission Maintenance for 10 Years With Thiopurines in Ulcerative Colitis
  Satohiro Matsumoto, Hirosato Mashima
  Crohn's & Colitis 360.2021;[Epub]     CrossRef
• Treatment of Inflammatory Bowel Disease: A Comprehensive Review
  Zhaobei Cai, Shu Wang, Jiannan Li
  Frontiers in Medicine.2021;[Epub]     CrossRef
• Optimizing the Use of Current Treatments and Emerging Therapeutic Approaches to Achieve Therapeutic Success in Patients with Inflammatory Bowel Disease
  Hiroshi Nakase
  Gut and Liver.2020; 14(1): 7.     CrossRef
• The Leading Edge of the Treatment of Inflammatory Bowel Disease
  Hiroshi Nakase
  Nihon Naika Gakkai Zasshi.2020; 109(6): 1145.     CrossRef
• Predictive Role of NUDT15 Variants on Thiopurine-Induced Myelotoxicity in Asian Inflammatory Bowel Disease Patients
  Natalia Sutiman, Sylvia Chen, Khoon Lin Ling, Sai Wei Chuah, Wai Fook Leong, Vinayak Nadiger, Madeline Tjai, Chris San Choon Kong, Brian John Schwender, Webber Chan, Hang Hock Shim, Wee Chian Lim, Chiea Chuen Khor, Yin Bun Cheung, Balram Chowbay
  Pharmacogenomics.2018; 19(1): 31.     CrossRef
• NUDT15,FTO, andRUNX1genetic variants and thiopurine intolerance among Japanese patients with inflammatory bowel diseases
  Toshiyuki Sato, Tetsuya Takagawa, Yoichi Kakuta, Akihiro Nishio, Mikio Kawai, Koji Kamikozuru, Yoko Yokoyama, Yuko Kita, Takako Miyazaki, Masaki Iimuro, Nobuyuki Hida, Kazutoshi Hori, Hiroki Ikeuchi, Shiro Nakamura
  Intestinal Research.2017; 15(3): 328.     CrossRef
• Clinical Efficacy of Beclomethasone Dipropionate in Korean Patients with Ulcerative Colitis
  Yoon Jee Lee, Jae Hee Cheon, Jae Hyun Kim, SunHo Yoo, Hyun Jung Lee, Soo Jung Park, Sung Pil Hong, Tae Il Kim, Won Ho Kim
  Yonsei Medical Journal.2017; 58(1): 144.     CrossRef
• Rate and Predictors of Mucosal Healing in Ulcerative Colitis Treated with Thiopurines: Results of a Multicentric Cohort Study
  Caroline Prieux-Klotz, Stéphane Nahon, Aurelien Amiot, Leila Sinayoko, Carole Galéano-Cassaz, Stanislas Chaussade, Romain Coriat, Pierre Lahmek, Vered Abitbol
  Digestive Diseases and Sciences.2017; 62(2): 473.     CrossRef
• Effect of mucosal healing (Mayo 0) on clinical relapse in patients with ulcerative colitis in clinical remission
  Jae Hyun Kim, Jae Hee Cheon, Yehyun Park, Hyun Jung Lee, Soo Jung Park, Tae Il Kim, Won Ho Kim
  Scandinavian Journal of Gastroenterology.2016; 51(9): 1069.     CrossRef
• Is Long-Term Therapy With Thiopurines Effective for Maintaining Remission in Patients With Moderate-To-Severe Ulcerative Colitis?
  Seong Ran Jeon, Won Ho Kim
  Intestinal Research.2015; 13(3): 191.     CrossRef

Behçet's disease (BD) is a systemic vasculitis, while myelodysplastic syndrome (MDS) is a heterogeneous group of clonal hematologic disorders characterized by ineffective hematopoiesis. Some studies suggest a relationship between MDS and BD, especially intestinal BD, and trisomy 8 seems to play an important role in both diseases. There are several reports on patients with BD comorbid with MDS involving trisomy 8 that frequently have intestinal lesions refractory to conventional medical therapies. Tumor necrosis factor (TNF)-α is strongly involved in the pathophysiology of several autoimmune diseases such as rheumatoid arthritis, inflammatory bowel disease, and BD. In addition, TNF-α plays an important role in the pathophysiology of MDS by inhibiting normal hematopoiesis and inducing the programmed cell death of normal total bone marrow cells and normal CD34+ cells. Recent clinical reports demonstrate the favorable effect of TNF-α antagonists in patients with refractory intestinal BD and in those with MDS. We present the case of a patient with intestinal BD and MDS involving trisomy 8 who was successfully treated with adalimumab.

Citations

Citations to this article as recorded by  

• The Expanding Spectrum of Autoinflammatory Diseases
  Kiyoshi Migita, Yuya Fujita, Tomoyuki Asano, Shuzo Sato
  Internal Medicine.2023; 62(1): 43.     CrossRef
• Refractory Intestinal Behçet-Like Disease Associated with Trisomy 8 Myelodysplastic Syndrome Resolved by Parenteral Nutrition
  Ryo Takahashi, Yasuo Matsubara, Satoshi Takahashi, Kazuaki Yokoyama, Lim Lay Ahyoung, Michiko Koga, Hiroyuki Sakamoto, Narikazu Boku, Dai Shida, Hiroshi Yotsuyanagi
  Case Reports in Gastroenterology.2023; 17(1): 287.     CrossRef
• The Expanding Spectrum of Autoinflammatory Diseases
  Kiyoshi Migita, Yuya Fujita, Tomoyuki Asano, Shuzo Sato
  Internal Medicine.2022;[Epub]     CrossRef
• CAISC: A software to integrate copy number variations and single nucleotide mutations for genetic heterogeneity profiling and subclone detection by single-cell RNA sequencing
  Jeerthi Kannan, Liza Mathews, Zhijie Wu, Neal S. Young, Shouguo Gao
  BMC Bioinformatics.2022;[Epub]     CrossRef
• Autoimmune disorders associated with myelodysplastic syndromes: clinical, prognostic and therapeutic implications
  Claudio Fozza, Andrea Murtas, Giovanni Caocci, Giorgio La Nasa
  Leukemia Research.2022; 117: 106856.     CrossRef
• Advances in Management of Intestinal Behçet’s Disease: A Perspective From Gastroenterologists
  Jae Hee Cheon
  Journal of Rheumatic Diseases.2021; 28(1): 4.     CrossRef
• Syndrome de pseudo-Behçet et autres manifestations dysimmunitaires associées aux syndromes myélodysplasiques avec trisomie 8
  N. Wesner, P. Fenaux, V. Jachiet, L. Ades, O. Fain, A. Mekinian
  La Revue de Médecine Interne.2021; 42(3): 170.     CrossRef
• The Clinical Features of Intestinal Disease in Myelodysplastic Syndromes with Trisomy 8
  Yusuke Honzawa
  Nippon Daicho Komonbyo Gakkai Zasshi.2021; 74(10): 594.     CrossRef
• Update on the Treatment of Behcet’s Disease of the Small Bowel with Biologic Agents
  Yehyun Park, Jae Hee Cheon
  Current Gastroenterology Reports.2020;[Epub]     CrossRef
• How to treat myelodysplastic syndrome with clinical features resembling Behçet syndrome: a case-based systematic review
  Umut Yilmaz, Muhlis Cem Ar, Sinem Nihal Esatoglu, Isil Bavunoglu, Yusuf Ziya Erzin, Ali Ibrahim Hatemi, Suleyman Yildirim, Gülen Hatemi, Aykut Ferhat Celik
  Annals of Hematology.2020; 99(6): 1193.     CrossRef
• Evidence-based diagnosis and clinical practice guidelines for intestinal Behçet’s disease 2020 edited by Intractable Diseases, the Health and Labour Sciences Research Grants
  Kenji Watanabe, Satoshi Tanida, Nagamu Inoue, Reiko Kunisaki, Kiyonori Kobayashi, Masakazu Nagahori, Katsuhiro Arai, Motoi Uchino, Kazutaka Koganei, Taku Kobayashi, Mitsuhiro Takeno, Fumiaki Ueno, Takayuki Matsumoto, Nobuhisa Mizuki, Yasuo Suzuki, Tadakaz
  Journal of Gastroenterology.2020; 55(7): 679.     CrossRef
• Sonic hedgehog signaling pathway in Myelodysplastic Syndrome: Abnormal activation and jervine intervention
  YuTing Qin, Ming Jiang, Nilupar Tuerxung, Huan Wang, Fang Zhao, Yin Zhen, Jianping Hao
  Gene.2020; 754: 144881.     CrossRef
• Gastrointestinal Behcet’s-like disease with myelodysplastic neoplasms with trisomy 8: a French case series and literature review
  Nadege Wesner, Louis Drevon, Alexis Guedon, Jean Baptiste Fraison, Benjamin Terrier, Salim Trad, Jean Emmanuel Kahn, Achille Aouba, Jerome Gillard, Matthieu Ponsoye, Thomas Hanslik, Clement Gourguechon, Eric Liozon, Kamel Laribi, Julien Rossignol, Olivier
  Leukemia & Lymphoma.2019; 60(7): 1782.     CrossRef
• Usefulness of Ustekinumab for Treating a Case of Myelodysplastic Syndrome-associated Inflammatory Bowel Disease
  Masashi Kono, Toshiharu Sakurai, Kazuki Okamoto, Tomoyuki Nagai, Yoriaki Komeda, Hiroshi Kashida, Kosuke Minaga, Ken Kamata, Mamoru Takenaka, Satoru Hagiwara, Tomohiro Watanabe, Naoshi Nishida, Eisuke Enoki, Hiroaki Inoue, Itaru Matsumura, Masatoshi Kudo
  Internal Medicine.2019; 58(14): 2029.     CrossRef
• Intestinal Behçet disease associated with myelodysplastic syndrome accompanying trisomy 8 successfully treated with abdominal surgery followed by hematopoietic stem cell transplantation
  Tomoyuki Asano, Shuzo Sato, Makiko Yashiro Furuya, Hiroshi Takahashi, Akiko Shichishima-Nakamura, Hiroshi Ohkawara, Tatsuo Fujiwara, Naohiko Gunji, Choichiro Hashimoto, Tomoyuki Momma, Motonobu Saito, Hiroshi Nakano, Guy Watanabe, Jumpei Temmoku, Yuya Fuj
  Medicine.2019; 98(46): e17979.     CrossRef
• Long-term maintenance of the mucosal healing induced by azacitidine therapy in a patient with intestinal Behçet’s-like disease accompanied with myelodysplastic syndrome involving trisomy 8
  Nahoko Tanaka, Hirotake Sakuraba, Hiroto Hiraga, Ko Mayama, Hidezumi Kikuchi, Dai Kishida, Yui Akemoto, Keisuke Hasui, Shinji Ota, Rina Watanabe, Yasuhisa Murai, Takato Maeda, Kosuke Kamata, Tetsuya Tatsuta, Manabu Sawaya, Daisuke Chinda, Tatsuya Mikami,
  Immunological Medicine.2019; 42(3): 135.     CrossRef
• Updated treatment strategies for intestinal Behçet’s disease
  Yong Eun Park, Jae Hee Cheon
  The Korean Journal of Internal Medicine.2018; 33(1): 1.     CrossRef
• High Incidence of Gastrointestinal Ulceration and Cytogenetic Aberration of Trisomy 8 as Typical Features of Behçet’s Disease Associated with Myelodysplastic Syndrome: A Series of 16 Consecutive Chinese Patients from the Shanghai Behçet’s Disease Database
  Yan Shen, Hai-Fen Ma, Dan Luo, Jian-Fei Cai, Jun Zou, Jian-Long Guan
  BioMed Research International.2018; 2018: 1.     CrossRef
• Anti-Tumor Necrosis Factor Therapy in Intestinal Beh Ccedil;et rsquo;s Disease
  Jihye Park, Jae Hee Cheon
  Gut and Liver.2018; 12(6): 623.     CrossRef
• Update on the Medical Management of Gastrointestinal Behçet’s Disease
  Giuseppe Lopalco, Donato Rigante, Vincenzo Venerito, Claudia Fabiani, Rossella Franceschini, Michele Barone, Giovanni Lapadula, Mauro Galeazzi, Bruno Frediani, Florenzo Iannone, Luca Cantarini
  Mediators of Inflammation.2017; 2017: 1.     CrossRef
• Risk factors and outcomes of acute lower gastrointestinal bleeding in intestinal Behçet’s disease
  Jihye Park, Jae Hee Cheon, Yong Eun Park, Yoon Jee Lee, Hyun Jung Lee, Soo Jung Park, Sung Pil Hong, Tae Il Kim, Won Ho Kim
  International Journal of Colorectal Disease.2017; 32(5): 745.     CrossRef
• 18F-FDG PET/CT Findings in Two Cases With Myelodysplastic Syndrome Accompanied by Behçet’s Disease
  Kimiteru Ito, Kazuo Kubota
  Clinical Nuclear Medicine.2016; 41(8): e392.     CrossRef
• Multiple colonic ulcers associated with trisomy 8: serial changes in colonoscopic findings
  Shunichi Yanai, Shotaro Nakamura, Keisuke Kawasaki, Shigeki Ito, Tamotsu Sugai, Takayuki Matsumoto
  Clinical Journal of Gastroenterology.2016; 9(5): 298.     CrossRef
• Acute Monocytic Leukemia Masquerading Behçet’s Disease-Like Illness at Onset in an Elderly Female
  Shigeru Koba, Toshio Sekioka, Sorou Takeda, Aya Miyagawa-Hayashino, Keisuke Nishimura, Shinsaku Imashuku
  Case Reports in Hematology.2016; 2016: 1.     CrossRef

Human cytomegalovirus (HCMV) is a member of the herpesvirus family. HCMV infection persists throughout the host lifespan in a latent state following primary infection. The ability of HCMV to escape control by the host immune system and its resulting reactivation suggests the importance of ongoing immune surveillance in the prevention of HCMV reactivation. HCMV is a common cause of opportunistic infection that causes severe and fatal disease in immune-compromised individuals. In inflammatory bowel disease patients, particularly those with ulcerative colitis (UC), HCMV is often reactivated because these patients are frequently treated with immunosuppressive agents. This reactivation exacerbates colitis. Additionally, HCMV infection can induce severe colitis, even in patients with UC who have never been treated with immunosuppressive agents. However, the role of HCMV in colonic inflammation in patients with UC remains unclear. Here, we present previous and current clinical data on the diagnosis and treatment of HCMV infection in UC. Additionally, our experimental data from a newly established mouse model mimicking UC with concomitant CMV infection clearly demonstrate that inflammation could result in the exacerbation of UC disease activity with induction of HCMV reactivation. In summary, optimal control of colonic inflammation should be achieved in UC patients who are refractory to conventional immunosuppressive therapies and are positive for HCMV.

Citations

Citations to this article as recorded by  

• Predictive Factors of Cytomegalovirus Colonic Reactivation in Patients with Active Ulcerative Colitis
  Alexandre Jentzer, Aymeric Cantais, Xavier Roblin, Mathilde Barrau, Arnauld Garcin, Thomas Bourlet, Bruno Pozzetto, Sylvie Pillet
  Viruses.2025; 17(4): 555.     CrossRef
• A case of ulcerative colitis in a patient undergoing surgery due to exacerbation resulting in toxic megacolon after SARS-CoV-2 vaccination
  Ryota Ogihara, Minoru Matsuura, Takuya Ishida, Hiromu Morikubo, Tatsuya Mitsui, Daisuke Saito, Jun Miyoshi, Junji Shibahara, Eiji Sunami, Tadakazu Hisamatsu
  Clinical Journal of Gastroenterology.2025;[Epub]     CrossRef
• Impact of cytomegalovirus on outcomes in acute severe ulcerative colitis: a retrospective observational study
  Dazhong Huang, Michael Rennie, Alicia Krasovec, Shyam Nagubandi, Sichang Liu, Edward Ge, Barinder Khehra, Michael Au, Shobini Sivagnanam, Vu Kwan, Claudia Rogge, Nikola Mitrev, Viraj Kariyawasam
  Therapeutic Advances in Chronic Disease.2024;[Epub]     CrossRef
• Cytomegalovirus in Ulcerative Colitis: An Unwanted “Guest”
  Danusia Onisor, Olga Brusnic, Simona Mocan, Mircea Stoian, Calin Avram, Adrian Boicean, Daniela Dobru
  Pathogens.2024; 13(8): 650.     CrossRef
• The association between antigenemia, histology with immunohistochemistry, and mucosal PCR in the diagnosis of ulcerative colitis with concomitant human cytomegalovirus infection
  Tsukasa Yamawaka, Hiroki Kitamoto, Masanori Nojima, Tomoe Kazama, Kohei Wagatsuma, Keisuke Ishigami, Shuji Yamamoto, Yusuke Honzawa, Minoru Matsuura, Hiroshi Seno, Hiroshi Nakase
  Journal of Gastroenterology.2023; 58(1): 44.     CrossRef
• Microscopic observations of sites and forms of ettringite in the microstructure of deteriorated concrete
  Y. Ando, H. Shinichi, T. Katayama, K. Torii
  Materiales de Construcción.2022; 72(346): e283.     CrossRef
• Ulcerative Colitis and Its Association with Cytomegalovirus
  梦鸽 李
  Advances in Clinical Medicine.2022; 12(06): 5506.     CrossRef
• Current Status of Opportunistic Infection in Inflammatory Bowel Disease Patients in Asia: A Questionnaire-Based Multicenter Study
  Hong Yang, Zhihua Ran, Meng Jin, Jia-Ming Qian
  Gut and Liver.2022; 16(5): 726.     CrossRef
• Impact of Dextran-Sodium-Sulfate-Induced Enteritis on Murine Cytomegalovirus Reactivation
  Alexandre Jentzer, Sébastien Fauteux-Daniel, Paul Verhoeven, Aymeric Cantais, Melyssa Yaugel Novoa, Fabienne Jospin, Blandine Chanut, Nicolas Rochereau, Thomas Bourlet, Xavier Roblin, Bruno Pozzetto, Sylvie Pillet
  Viruses.2022; 14(12): 2595.     CrossRef
• Human Cytomegalovirus and Autoimmune Diseases: Where Are We?
  Francesca Gugliesi, Selina Pasquero, Gloria Griffante, Sara Scutera, Camilla Albano, Sergio Fernando Castillo Pacheco, Giuseppe Riva, Valentina Dell’Oste, Matteo Biolatti
  Viruses.2021; 13(2): 260.     CrossRef
• Clinical Significance of Residual Nonrectal Inflammation in Ulcerative Colitis Patients in Clinical Remission
  Jongbeom Shin, Sung Min Kong, Tae Jun Kim, Eun Ran Kim, Sung Noh Hong, Dong Kyung Chang, Young-Ho Kim
  Gut and Liver.2021; 15(3): 401.     CrossRef
• Clinical characteristics of cytomegalovirus gastritis
  Dan Chen, Ruijie Zhao, Wei Cao, Weixun Zhou, Ying Jiang, Shangzhu Zhang, Yang Chen, Guijun Fei, Ji Li, Jiaming Qian
  Medicine.2020; 99(5): e18927.     CrossRef
• Current Diagnostic and Therapeutic Approaches to Cytomegalovirus Infections in Ulcerative Colitis Patients Based on Clinical and Basic Research Data
  Yoshihiro Yokoyama, Tsukasa Yamakawa, Takehiro Hirano, Tomoe Kazama, Daisuke Hirayama, Kohei Wagatsuma, Hiroshi Nakase
  International Journal of Molecular Sciences.2020; 21(7): 2438.     CrossRef
• Cytomegalovirus and Inflammatory Bowel Diseases (IBD) with a Special Focus on the Link with Ulcerative Colitis (UC)
  Alexandre Jentzer, Pauline Veyrard, Xavier Roblin, Pierre Saint-Sardos, Nicolas Rochereau, Stéphane Paul, Thomas Bourlet, Bruno Pozzetto, Sylvie Pillet
  Microorganisms.2020; 8(7): 1078.     CrossRef
• Cytomegalovirus Enterocolitis in a Patient with Refractory Immune-Related Colitis
  Yoki Furuta, Hideaki Miyamoto, Hideaki Naoe, Miki Shimoda, Yukari Hinokuma, Tomohiro Miyamura, Azusa Miyashita, Satoshi Fukushima, Motohiko Tanaka, Yutaka Sasaki
  Case Reports in Gastroenterology.2020; 14(1): 103.     CrossRef
• Exacerbation causes among inflammatory bowel disease patients in Guilan Province north of Iran
  Raheleh Sadat Hosseini, Fariborz Mansour-Ghanaei, Afshin Shafaghi, Amineh Hojati, Farahnaz Joukar, Zahra Atrkar Roushan, Fakhri Alsadat Hosseini, Sara Mavaddati
  Journal of Coloproctology.2019; 39(02): 138.     CrossRef
• Management of elderly ulcerative colitis in Japan
  Masaaki Higashiyama, Akira Sugita, Kazutaka Koganei, Kenji Wanatabe, Yoko Yokoyama, Motoi Uchino, Masakazu Nagahori, Makoto Naganuma, Shigeki Bamba, Shingo Kato, Ken Takeuchi, Teppei Omori, Tomohisa Takagi, Satohiro Matsumoto, Mitsuo Nagasaka, Shintaro Sa
  Journal of Gastroenterology.2019; 54(7): 571.     CrossRef
• Evidence-based consensus on opportunistic infections in inflammatory bowel disease (republication)
  
  Intestinal Research.2018; 16(2): 178.     CrossRef
• Cytomegalovirus infection in ulcerative colitis assessed by quantitative polymerase chain reaction: risk factors and effects of immunosuppressants
  Yujiro Henmi, Kazuki Kakimoto, Takuya Inoue, Kei Nakazawa, Minori Kubota, Azusa Hara, Takashi Mikami, Yutaka Naka, Yuki Hirata, Yoshimasa Hirata, Taisuke Sakanaka, Sadaharu Nouda, Toshihiko Okada, Ken Kawakami, Toshihisa Takeuchi, Kazunari Tominaga, Kazuh
  Journal of Clinical Biochemistry and Nutrition.2018; 63(3): 246.     CrossRef
• Treatment of inflammatory bowel disease by leukocytapheresis
  Emre Gerçeker, Hakan Yüceyar, Elmas Kasap, Ufuk Demirci, Burcu Ceren Ekti, İsmet Aydoğdu, Mine Miskioğlu
  Transfusion and Apheresis Science.2017; 56(3): 421.     CrossRef
• Targeting cytomegalovirus during ulcerative colitis flare-ups
  Hiroshi Nakase, Kei Onodera
  Expert Review of Gastroenterology & Hepatology.2016; 10(10): 1119.     CrossRef
• Natural History of Elderly-onset Ulcerative Colitis: Results from a Territory-wide Inflammatory Bowel Disease Registry
  Hai Yun Shi, Francis K. L. Chan, Wai Keung Leung, Michael K. K. Li, Chi Man Leung, Shun Fung Sze, Jessica Y. L. Ching, Fu Hang Lo, Steve W. C. Tsang, Edwin H. S. Shan, Lai Yee Mak, Belsy C. Y. Lam, Aric J. Hui, Sai Ho Wong, Marc T. L. Wong, Ivan F. N. Hun
  Journal of Crohn's and Colitis.2016; 10(2): 176.     CrossRef
• Cytomegalovirus in inflammatory bowel disease: A systematic review
  Tessa EH Römkens
  World Journal of Gastroenterology.2016; 22(3): 1321.     CrossRef
• Treatment of inflammatory bowel disease in Asia: the results of a multinational web-based survey in the 2ndAsian Organization of Crohn's and Colitis (AOCC) meeting in Seoul
  Hiroshi Nakase, Bora Keum, Byoung Duk Ye, Soo Jung Park, Hoon Sup Koo, Chang Soo Eun
  Intestinal Research.2016; 14(3): 231.     CrossRef
• Risk Factors and Clinical Outcomes Associated with Cytomegalovirus Colitis in Patients with Acute Severe Ulcerative Colitis
  Ho-Su Lee, Sang Hyoung Park, Sung-Han Kim, Jihun Kim, Jene Choi, Hyo Jeong Lee, Wan Soo Kim, Jeong-Mi Lee, Min Seob Kwak, Sung Wook Hwang, Dong-Hoon Yang, Kyung-Jo Kim, Byong Duk Ye, Jeong-Sik Byeon, Seung-Jae Myung, Yong Sik Yoon, Chang Sik Yu, Jin-Ho Ki
  Inflammatory Bowel Diseases.2016; 22(4): 912.     CrossRef
• Human cytomegalovirus encoded chemokine receptor US28 activates the HIF-1α/PKM2 axis in glioblastoma cells
  Raymond H. de Wit, Azra Mujić-Delić, Jeffrey R. van Senten, Alberto Fraile-Ramos, Marco Siderius, Martine J. Smit
  Oncotarget.2016; 7(42): 67966.     CrossRef
• Cytomegalovirus Colitis, Cytomegalovirus Hepatitis and Systemic Cytomegalovirus Infection: Common Features and Differences
  Hiroshi Nakase, Hans Herfarth
  Inflammatory Intestinal Diseases.2016; 1(1): 15.     CrossRef
• Infliximab Does Not Worsen Outcomes During Flare-ups Associated with Cytomegalovirus Infection in Patients with Ulcerative Colitis
  Sylvie Pillet, Camille Jarlot, Mathilde Courault, Emilie Del Tedesco, Renaud Chardon, Pierre Saint-Sardos, Emilie Presles, Jean-Marc Phelip, Philippe Berthelot, Bruno Pozzetto, Xavier Roblin
  Inflammatory Bowel Diseases.2015; 21(7): 1580.     CrossRef
• Evaluation of a multiplex PCR assay for detection of cytomegalovirus in stool samples from patients with ulcerative colitis
  Saifun Nahar
  World Journal of Gastroenterology.2015; 21(44): 12667.     CrossRef
• Author's Reply
  Jaeyoung Chun, Jong Pil Im
  Intestinal Research.2015; 13(2): 184.     CrossRef
• Reply: Careful Assessment Is Needed in Patients with Ulcerative Colitis with Evidence of Cytomegalovirus Reactivation
  You Sun Kim, Joo Sung Kim
  Gut and Liver.2015; 9(2): 254.     CrossRef
• Usefulness of the Cytomegalovirus Antigenemia Assay in Patients With Ulcerative Colitis
  Jaeyoung Chun, Changhyun Lee, Ji-eun Kwon, Sung Wook Hwang, Sang Gyun Kim, Joo Sung Kim, Hyun Chae Jung, Jong Pil Im
  Intestinal Research.2015; 13(1): 50.     CrossRef
• Long-Term Outcomes of Cytomegalovirus Reactivation in Patients with Moderate to Severe Ulcerative Colitis: A Multicenter Study
  You Sun Kim, Young-Ho Kim, Joo Sung Kim, Seong Yeon Jeong, Soo Jeong Park, Jae Hee Cheon, Byong Duk Ye, Sung-Ae Jung, Young Sook Park, Chang Hwan Choi, Kyeung Ok Kim, Byung Ik Jang, Dong Soo Han, Suk-Kyun Yang, Won Ho Kim
  Gut and Liver.2014; 8(6): 643.     CrossRef